HomeCompareDCHPF vs BTI

DCHPF vs BTI: Dividend Comparison 2026

DCHPF yields 1.17% · BTI yields 5.38%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DCHPF wins by $7.85M in total portfolio value· pulled ahead in Year 4
10 years
DCHPF
DCHPF
● Live price
1.17%
Share price
$46.90
Annual div
$0.55
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$7.89M
Annual income
$6,778,497.55
Full DCHPF calculator →
BTI
BTI
● Live price
5.38%
Share price
$58.47
Annual div
$3.15
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.7K
Annual income
$2,786.64
Full BTI calculator →

Portfolio growth — DCHPF vs BTI

📍 DCHPF pulled ahead of the other in Year 4

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDCHPFBTI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DCHPF + BTI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
DCHPF pays
BTI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DCHPF
Annual income on $10K today (after 15% tax)
$99.68/yr
After 10yr DRIP, annual income (after tax)
$5,761,722.92/yr
BTI
Annual income on $10K today (after 15% tax)
$457.40/yr
After 10yr DRIP, annual income (after tax)
$2,368.64/yr
At 15% tax rate, DCHPF beats the other by $5,759,354.27/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DCHPF + BTI for your $10,000?

DCHPF: 50%BTI: 50%
100% BTI50/50100% DCHPF
Portfolio after 10yr
$3.96M
Annual income
$3,390,642.10/yr
Blended yield
85.55%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

DCHPF
No analyst data
Altman Z
4.3
Piotroski
6/9
BTI
Analyst Ratings
12
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$40.00
-31.6% upside vs current
Range: $40.00 — $40.00
Altman Z
2.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DCHPF buys
0
BTI buys
0
No recent congressional trades found for DCHPF or BTI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDCHPFBTI
Forward yield1.17%5.38%
Annual dividend / share$0.55$3.15
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%11.3%
Portfolio after 10y$7.89M$37.7K
Annual income after 10y$6,778,497.55$2,786.64
Total dividends collected$7.78M$14.3K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: DCHPF vs BTI ($10,000, DRIP)

YearDCHPF PortfolioDCHPF Income/yrBTI PortfolioBTI Income/yrGap
1$10,935$234.54$11,299$598.92$364.00BTI
2$12,179$479.37$12,794$703.91$615.00BTI
3$14,030$998.01$14,518$829.07$488.00BTI
4← crossover$17,161$2,148.88$16,513$978.64+$648.00DCHPF
5$23,275$4,912.97$18,827$1,157.84+$4.4KDCHPF
6$37,359$12,454.96$21,518$1,373.12+$15.8KDCHPF
7$77,342$37,367.67$24,657$1,632.46+$52.7KDCHPF
8$227,353$144,597.06$28,329$1,945.74+$199.0KDCHPF
9$1,037,762$794,493.85$32,637$2,325.33+$1.01MDCHPF
10$7,888,903$6,778,497.55$37,708$2,786.64+$7.85MDCHPF

DCHPF vs BTI: Complete Analysis 2026

DCHPFStock

Dechra Pharmaceuticals PLC develops, manufactures, regulates, markets, and sells veterinary pharmaceuticals and related products for veterinarians. It operates through three segments: European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development. The company offers various endocrinology, dermatology, analgesia and anesthesia, cardiovascular, and critical care products for dogs and cats; water soluble antibiotics, poultry vaccines, and pain management for poultry, pigs, and cattle; and lameness and pain management products for horses and ponies. It also provides pet nutrition products for supporting cats and dogs with various therapeutic conditions, such as allergies, obesity, heart, and kidney diseases. In addition, the company distributes veterinary pharmaceuticals and equipment; offers financial services; markets pet diets; and develops, regulates, manufactures, and markets crop protection. It markets its products through wholesaler and distributor networks. The company operates in the United Kingdom, Germany, rest of Europe, the United States, and internationally. Dechra Pharmaceuticals PLC was incorporated in 1997 and is headquartered in Northwich, the United Kingdom.

Full DCHPF Calculator →

BTIConsumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →
📬

Get this DCHPF vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DCHPF vs SCHDDCHPF vs JEPIDCHPF vs ODCHPF vs KODCHPF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.